In pulmonary tuberculosis, Mycobacterium tuberculosis bacteria reside in the alveoli and are in close proximity with the alveolar surfactant. Mycolic acid in its free form and as cord factor, constitute the major lipids of the mycobacterial cell wall. They can detach from the bacteria easily and are known to be moderately surface active. We hypothesize that these surface-active mycobacterial cell wall lipids could interact with the pulmonary surfactant and result in lung surfactant dysfunction. In this study, the major phospholipid of the lung surfactant, dipalmitoylphosphatidylcholine (DPPC) and binary mixtures of DPPC:phosphatidylglycerol (PG) in 9:1 and 7:3 ratios were modelled as lung surfactant monolayers and the inhibitory potential of mycolic acid and cord factor on the surface activity of DPPC and DPPC:PG mixtures was evaluated using Langmuir monolayers. The mycobacterial lipids caused common profile changes in all the isotherms: increase in minimum surface tension, compressibility and percentage area change required for change in surface tension from 30 to 10 mN/m. Higher minimum surface tension values were achieved in the presence of mycolic acid (18.2 ± 0.7 mN/m) and cord factor (13.28 ± 1.2 mN/m) as compared to 0 mN/m, achieved by pure DPPC film. Similarly higher values of compressibility (0.375 ± 0.005 m/mN for mycolic acid:DPPC and 0.197 ± 0.003 m/mN for cord factor:DPPC monolayers) were obtained in presence of mycolic acid and cord factor. Thus, mycolic acid and cord factor were said to be inhibitory towards lung surfactant phospholipids. Higher surface tension and compressibility values in presence of tubercular lipids are suggestive of an unstable and fluid surfactant film, which will fail to achieve low surface tensions and can contribute to alveolar collapse in patients suffering from pulmonary tuberculosis. In conclusion a biophysical inhibition of lung surfactant may play a role in the pathogenesis of tuberculosis and may serve as a target for the development of new drug loaded surfactants for this condition.
Introduction
Pulmonary tuberculosis is clinically the most commonly encountered form of tuberculosis. It is caused by the acid fast bacillus Mycobacterium tuberculosis. This killer disease alone is responsible for more than 2 million deaths a year [1] . In its pulmonary form, it is associated with a decrease in pulmonary compliance manifested as difficulty in breathing and decreased work capacity. The pathological changes observed in cases of pulmonary tuberculosis range from focal areas of alveolar collapse to patches of pneumonia and atelectasis. These pathologies are also associated clinically with lung surfactant dysfunction as seen in cases of adult respiratory distress syndrome [2] .
Mycobacteria responsible for tuberculosis are lodged in the pulmonary alveoli, which are in turn lined by the pulmonary surfactant. Close physical proximity between pulmonary surfactant and the tubercle bacilli could facilitate interactions between the pulmonary surfactant components and the surface exposed components of the mycobacteria. The mycobacterial cell wall is exceptionally rich in lipids, which constitute about 60% of its weight. These lipids are the major components of the mycobacterial capsule, which is exposed to the external environment [3] . Cell wall lipids are known to spontaneously shed into the culture medium [4] and simple gentle mechanical abrasion is known to release the superficial cell wall lipids into the medium [5] . The cord factor molecules are known to spontaneously diffuse into host cell membranes and result in functional loss [6] . These lipids could similarly get detached and shed into the pulmonary alveolar space, where they could interact with the pulmonary surfactant system. Earlier studies have established that mycolic acid extracted from mycobacteria are moderately surface active and those from M. tuberculosis collapse at surface pressures between 20 and 40 mN/m [7] . Thus, there is a possibility of lung surfactant dysfunction due to the presence of such surface-active mycobacterial lipids at the alveolar interface.
In this study, we have evaluated the surface activity of model surfactant lipid monolayers in the presence of graded amounts of mycolic acid and cord factor. Mycolic acid is the most abundant surface lipid of the mycobacterial cell wall and its structure is depicted in Fig. 1a . Mycolic acid is present in free and bound forms in the cell wall, when bound to the trehalose sugars, it forms cord factor known as 6,6 trehalose dimycolate as seen in Fig. 1b .
Lung surfactant is a mixture of phospholipids and surfactant specific proteins secreted by the type II pneumocytes in the alveoli. It is quickly adsorbed as a monomolecular film at the airaqueous interface and is a mixture of saturated and unsaturated phospholipids. Upon compression the more fluid phospholipids are squeezed out into the subphase and a condensed, solid packed film almost nearly consisting of saturated DPPC molecules is left behind at the interface [8] . Another recent school of thought is that there is pre-sorting or selective adsorption of DPPC to the interface and DPPC poor lipid is left behind in the subphase and recycled [9] .
In either case, there appears to be DPPC enrichment and the film at the interface behaves similar to that a of pure DPPC monolayer. DPPC is not only the most abundant lung surfactant phospholipid but also the main phospholipid endowing upon the lung surfactant its unique surface properties. Lung surfactant is known to adsorb quickly to the air-aqueous interface, and form a monolayer, which allows adjustments of surface tension with area during dynamic expiration and inspiration, allowing the film to finally attain the crucial near zero minimum surface tension needed to maintain alveolar stability. Clinically it reduces the work of breathing by increasing the lung compliance and resisting possible alveolar atelectasis. The inability to execute these properties is defined as surfactant dysfunction and the agents, which cause such changes are said to be inhibitory to lung surfactant function. Thus in surfactant dysfunction, zero minimum surface tension is not reached, causing the alveoli to collapse, requiring increased breathing efforts to re expand and stabilize the atelectatic alveoli [10] .
In this study, DPPC monolayer was hence chosen as the simplest model of lung surfactant. PG is the second most abundantly occurring phospholipid in lung surfactant and is known to aid DPPC adsorption to the air-aqueous interface [11] . Binary mixtures of DPPC:PG were hence also studied to evaluate the inhibitory potential of mycobacterial lipids.
Materials and methods

Materials
Synthetic 1,2 dipalmitoylphosphatidylcholine (>99% purity) was purchased from Sigma Chemicals Co. (St. Louis, USA) and used without further purification. The mycobacterial lipids-mycolic acid and cord factor (>98%) purity were also obtained from Sigma Chemicals Co. HPLC grade chloroform used for making the stock solutions was purchased from Merck Ltd., Mumbai. Analytical grade solvents, methanol and acetone, used for cleaning the Langmuir-Blodgett trough and salts namely sodium chloride (99.9% pure) and calcium chloride, used for preparing the subphase, were purchased from Sisco Research Laboratories, Mumbai, India. Water used in all experiments was doubly distilled and deionised using the MilliQ UV plus system (MILLIPORE Corp., USA) and had a resistivity of 18.2 M cm.
Methods
Protocols 2.2.1.1. Monolayer studies.
Surface activity studies were performed using a Langmuir-Blodgett apparatus (KSV instruments Ltd., Finland). It consists of a Teflon mini-trough (323 mm × 75 mm), equipped with two symmetrically moving surface barriers. The trough was mounted on a thermo regulated base plate and the temperature was maintained at 37 ± 0.5 • C by an external circulating water bath. The surface pressure (π) was measured continuously by a gold Wilhelmy plate connected to a microelectronic feedback system for surface pressure measurement. It has a dynamic range between 0 and 72 mN/m (surface tension of pure water at room temperature). The Wilhelmy plate was roughened each time before the start of the experiment so as to achieve complete wetting of the plate. The trough was triply cleaned with deionized water, methanol and acetone followed again by deionized water.
The surface of the subphase was cleaned by gently aspirating the minute particulate matter and cleanliness was confirmed by a zero reading of surface pressure. The subphase consisted of 0.9% sodium chloride with 2 mM calcium chloride. The pH was adjusted to 7.4 by adding tiny drops of sodium hydroxide. For the monolayer studies the mycobacterial lipid, DPPC and mycobacterial lipid-DPPC mixtures were spread as tiny droplets by a Hamilton syringe using chloroform as a spreading solvent.
All controls namely DPPC, DPPC:PG (9:1), DPPC:PG (7:3), MA and CF were studied at a surface concentration corresponding to 110Å 2 area per molecule. A wait period of 30 min was given for solvent evaporation before start of each experiment.
The barrier speed was 120.5 mm/min and there was no wait period between compression and expansion. This speed is less than the adult respiratory rates but is the maximum speed at which the barriers can be moved without disturbing the monolayer. Isotherms of surface pressure versus area were recorded while compressing the monolayers by 85%. Minimum surface tension was calculated at this maximally compressed point.
Mycobacterial lipid-surfactant mixed monolayer studies.
To evaluate the effect of each mycobacterial lipid on DPPC, mycolic acid and cord factor were mixed with DPPC individually forming the mycolic acid-DPPC and cord factor-DPPC mixtures. The extent of inhibition was evaluated by studying various ratios by weight of mycobacterial lipid-DPPC mixtures. A similar procedure was followed for evaluating the effect of mycolic acid-cord factor mixture on DPPC:PG monolayers.
Parameters
Parameters evaluated from the surface tension versus area isotherms were minimum surface tension attained at maximal compression, percentage area change required for a change in the surface tension value from 30 to 10 mN/m and compressibility.
Minimum surface tension
The most important property of pulmonary surfactant is to achieve low values of surface tension on compression at the air-aqueous interface. Near zero surface tension is observed on compression of films of the natural surfactant [12] . In our study, minimum surface tension is achieved at maximal compression and is calculated by subtracting the maximum surface pressure attained by the monolayer from the initial surface tension of the subphase. It is the most vital parameter for effective lung surfactant function as it represents surface tension achieved by lung surfactant on end expiration. Near zero minimum surface tension is essential for maintaining alveolar stability.
Percentage area change
An efficient pulmonary surfactant brings about a quick fall in surface tension with a small change in pulmonary area. The pulmonary equilibrium surface tension value is around 25-30 mN/m [13] . Surface tension values below 10 mN/m are needed for effective surfactant function [14] . With these practical pulmonary conditions in mind, the percentage area change needed to decrease the surface tension values from 30 to 10 mN/m was calculated.
Compressibility
Compressibility is a very sensitive parameter for studying the changes in molecular packing and orientation for a monolayer. For an efficient surfactant a low compressibility film is desired. A low compressibility film requires small changes in area for attaining low values of surface tension. This leaves behind a large surface area in the lungs for efficient gaseous exchange, which is particularly an advantage in respiratory disorders having a ventilation-perfusion dysfunction. In our study, compressibility was monitored across the surface tension ranging from 30 mN/m, which corresponds to the equilibrium surface tension at inspiration, to 10 mN/m, which is the minimum surface tension required for efficient lung surfactant function.
Compressibility is calculated by the formula
where A is the relative surface area and m is the slope of the surface tension-area curve at the chosen surface tension [15] .
Statistical analysis
The effect of mycobacterial surface lipids (used alone or as mixtures) on the surface properties of DPPC and DPPC:PG mixtures are compared by statistical analysis of the data. Statistical significance was evaluated by using one-way analysis of variance and the Newman-Keul's test (p < 0.05 was the cut-off value). mycolic acid on the surface activity of DPPC monolayers was studied. The minimum surface tension reached by the mycolic acid-DPPC combination in 1:1 ratio by weight is 18.20 ± 0.7 and 18.14 ± 0.98 mN/m for mycolic acid-DPPC in 0.75:1 ratio. Lower values of surface tension varying between 12 and 9 mN/m were obtained for the other two ratios. Statistical analysis shows that there exists a significant difference between the surface activity of the mycolic acid-DPPC mixed monolayers and the pure DPPC monolayer. This significant difference is present across all the varying concentrations of mycolic acid-DPPC mixed monolayers studied as seen in Fig. 3 . Also it is worth noting that there is no significant difference between the surface tension values of the mycolic acid-DPPC mixed monolayers when used in 1:1 and 0.75:1 ratios. The minimum surface tension of the mycolic acid-DPPC monolayers is closer to that of pure mycolic acid alone which attained a value of 24.12 ± 0.71 mN/m. Thus, the presence of mycolic acid within the DPPC film, at all the concentrations studied fluidizes the film and prevents it from reaching surface tensions <10 mN/m.
Experimental results
Effect of mycobacterial lipids on minimum surface tension
Similarly, high values of minimum surface tension were obtained by cord factor-DPPC mixed films as seen in Fig. 4 . The values attained by the cord factor-DPPC mixed monolayer in 1:1 ratio by weight is 13.28 ± 1.2 mN/m while 12.92 ± 1.1 mN/m was recorded for cord factor-DPPC in 0.75:1 ratio. Lower values ranging between 10 and 8 mN/m were obtained for the other two ratios. Significant statistical difference was found to exist between all the cord factor-DPPC mixed monolayers and pure DPPC. No statistical difference was observed between the minimum surface tension values attained by the cord factor-DPPC combinations in 1:1 and 0.75:1 ratio, a phenomenon also observed with mycolic acid-DPPC mixtures.
We also evaluated effects of the mixtures of cord factor and mycolic acid on DPPC monolayer. Minimum surface tension achieved by the triple component mixed lipid film is 16.62 ± 0.63 mN/m. This value lies in between the higher value of surface tension obtained by mycolic acid-DPPC monolayer and the lower one obtained by the cord factor-DPPC monolayer. Both mycolic acid and cord factor, individually or in combination, significantly inhibit the surface activity of DPPC and hence could result in surfactant dysfunction. Similarly, very high values of surface tension were obtained for the DPPC:PG mixed monolayers in the presence of mycobacterial lipids as seen in the surface tension-area isotherms in Fig. 5 . All the combinations of binary phospholipid:inhibitor mixtures resulted in a significant rise in the minimum surface tension. Statistically significant Fig. 5 . Surface activity of the mycobacterial lipid-DPPC:PG mixtures in varying ratios. PL1, phospholipid mixture of DPPC:PG in (9:1) ratio, PL2, phospholipid mixture of DPPC:PG in (7:3) ratio. PG, phosphatidylglycerol; CF, cord factor; MA, mycolic acid; DPPC, dipalmitoylphosphatidylcholine. Both the mycobacterial lipids resulted in significant inhibition of DPPC surface activity. Presence of phosphatidylglycerol resulted in significant increase in minimum surface tension of DPPC.
inhibitory effects of mycobacterial lipids on minimum surface tension of surfactant phospholipids was observed with ANOVA (F = 244.11, F critical = 1.95, p < 0.001) and Newman-Keul's test (p < 0.05).
Effect of mycobacterial lipids on compressibility
DPPC films reached low compressibility values of about 0.017 ± 0.003 m/mN as can be seen in Fig. 6 . Higher values were obtained for the mycolic acid-DPPC mixed monolayers, with the highest value (0.375 ± 0.005 m/mN) reached by the mycolic acid-DPPC monolayer in 1:1 ratio by weight. The peaks observed in the compressibility-surface tension curves could result from the reorientation of the mycolic acid molecules and unfolding of the asymmetric hydrocarbon chains. This could also correspond to phase transitions occurring in the monolayer. Re-orientation and extension of mycolic acids with film compression was also observed by Hasegawa and Leblanc [7] with resulting variations in limiting molecular area of different mycolic acids.
Such sudden increases in compressibility suggest monolayer instability caused by the presence of the mycolic acid molecules. The values of compressibility decrease with a decrease in the amount of mycolic acid in the mixed monolayer, however even in a ratio of 0.1:1, it is still much higher as compared to that of the pure DPPC film. The increase in compressibility has a negative connotation for lung surfactant surface activity as it indicates sudden destabilization of the lung surfactant film due to mycobacterial lipids and a need to increase the monolayer compression to achieve zero minimum surface tension. This implies the presence of a poorly packed surfactant film leading to increased work of breathing. A similar phenomenon is observed in case of cord factor-DPPC mixed films as seen in Fig. 7 . However the compressibility values obtained by the cord factor-DPPC films are lower than those obtained by the mycolic acid-DPPC films which imply that mycolic acid is more inhibitory towards surfactant function than cord factor. Higher compressibility values imply a more fluid and loosely packed film which is also evident with the increased value of percentage area (%) change seen in these cases. In accordance with the compressibility results, the percentage area change required by the cord factor-DPPC film reaching a surface tension of 10 mN/m is less compared to that of mycolic acid-DPPC film. Presence of the tubercular lipids prevents close packing of the DPPC molecules and hinders their surface activity, leading to formation of films with high compressibility.
Effect of lipids on percentage area change
Very high values of surface tension reached by both the mycolic acid-DPPC mixture and cord factor-DPPC mixture restrict us from calculating this parameter. The parameter was calculated for only those cases of which achieved a surface tension of ≤10 mN/m. As seen in Table 1 , the values for per- Table 1 Effect of the mycolic acid and cord factor on DPPC percentage area change when used in 0. centage area change in descending order are 66.31 ± 1.2% for mycolic acid-DPPC mixture in 0.1:1 ratio, 45.99 ± 1.6% for cord factor-DPPC in 0.1:1 ratio by weight and 32.25 ± 2.6% for DPPC. This indicates that even at very low amounts of mycolic acid, the mycolic acid-DPPC film requires much larger area change to reach a surface tension value of 10 mN/m, which in turn reflects a poor surfactant function. A similar pattern is followed by cord factor-DPPC mixed monolayer.
Discussion
Mycobacterial lipids
Mycolic acid and cord factor, were studied for evaluating their inhibitory effects on phospholipid films. Lipids are the major constituents of the mycobacterial cell wall and constitute about 60% by weight. Of these lipids, the phenolic glycolipids and mycolic acid molecules are located on the cell wall surface [16] . Mycolic acid was chosen for the study because of its relative abundance in the mycobacterial cell wall as well as its unique structure. Almost 40% of the mycobacterial cell wall lipid is mycolic acid [17] . Mycolic acids are high molecular weight ␣ alkyl ␤ hydroxy fatty acids having asymmetrical and folded hydrocarbon chains. They are unique with an asymmetric structure about the head group. This consists of the exceptionally long hydrocarbon chains referred to as the mero group which is associated with the short chain of C 22 -C 25 hydrocarbons. The folding and unfolding of mycolic acid chains can influence their roles as permeability barriers for drugs [18] . Inhibition of mycolic acid synthesis by antitubercular drug isoniazid is known to result in destruction of mycobacterial cell wall. The extent of hydrophobicity exhibited by the mycolic acid molecules depends upon the nature of the hydrocarbon chains and their orientation.
Mycolic acids vary in their type depending upon the bacterial strain. The ␣-mycolic acid and keto-mycolic acid are the major mycolic acids occurring in M. tuberculosis [19] . In a study by Hasegawa and Leblanc [7] the ␣-mycolic acid from M. tuberculosis reached an early collapse at 20 mN/m surface pressure as against the keto-mycolic acid, which attained a surface pressure of around 40 mN/m. The ␣-mycolic acid is one of the most hydrophobic mycolic acids proposed to exist as double folded hydrocarbon chain molecules in expanded state while keto-mycolic acid exists as triply folded hydrocarbon chains resulting in large molecular areas. Such differences in the hydrocarbon chain folding are thought to be responsible for the packing differences and varying surface properties of these mycolic acids.
In our study, to closely simulate the surface behaviour of mycolic acids from M. tuberculosis, a mixture of the different mycolic acids extracted from the cell wall of M. tuberculosis was used. This gave us the advantage to study the net effect of the different mycolic acids when present as mixture as expected in vivo in the mycobacterial cell wall, on the phospholipid monolayers. In our study mycolic acid from M. tuberculosis reached a surface pressure value of about 43 mN/m. This surface pressure reflects the net effect of different mycolic acids, when coexistent in a monolayer. The surface pressure obtained by the mixture of the different mycolic acids is similar to that attained by ketomycolic acid by Hasegawa and Leblanc [7] . This could also be because of collapse of some of the ␣-mycolic acid molecules, when the monolayer is compressed beyond its collapse pressure of 20 mN/m. The net surface pressure reached could hence be a function of the relative amounts of the individual mycolic acids present in the monolayer. Further, the subphase temperature and pH of the two studies vary. The studies mentioned above were performed at 25 • C with the pH of subphase adjusted to 6.2 whereas the present study evaluates the surface activity at the physiological temperature of 37 • C and pH of 7.4. The latter conditions more closely simulate the in vivo conditions expected in the lungs.
Mycolic acids also occur on the mycobacterial cell wall surface associated with trehalose sugar forming cord factor. Cord factor is an abundantly occurring surface exposed lipid of mycobacterium. It is a symmetrically dimycolated disaccharide and contains two mycolic acid molecules attached to trehalose sugar [20] . It is thought to damage the host cell membrane by altering the membrane packing and organization. The cord factor linked mycolic acids have differing chain lengths and structures which are species dependent. The cord factor from M. tuberculosis contains highly hydrophobic dicyclopropane and methoxy groups on their hydrocarbon chain.
In a study by Almong and Mannella [21] , cord factor molecules attained surface pressures between 47 and 50 mN/m at 22 • C. In our study, cord factor was found to attain surface pressures of about 40 mN/m. The surface properties could differ due to the differences in the experimental conditions. At a higher temperature of 37 • C, a more fluid cord factor monolayer could be formed which could result in attainment of lower surface pressures.
Thus, it is seen that both mycolic acid and cord factor have moderate surface activity as against the highly surface active DPPC monolayer. The mere coexistence of these molecules in DPPC films was predicted to result in poor surface performance of the mixed film as each molecule would compete for space and exhibit its own surface activity. These molecules could biophysically inhibit the DPPC surface properties, a wellknown mechanism for surfactant dysfunction. The results presented in our study demonstrate that both the mycobacterial cell wall lipids (i.e. cord factor and mycolic acid), individually and in combination deteriorated the surface properties of DPPC and DPPC:PG monolayers, components of pulmonary surfactant.
Mycobacterial lipid-DPPC isotherms
In our studies, mycolic acid raised the minimum surface tension attained by the DPPC monolayers to values of about 18 mN/m while cord factor raised the minimum surface tension value to about 13 mN/m.
Near horizontal plateaus in the surface tension-area isotherms were observed for 1:1 and 0.75:1 ratios of mycolic acid:DPPC mixtures. This change in the nature of isotherms could be due to the mycolic acid molecules, which could hin-der the close packing and reorientation of the DPPC molecules. This characteristic near flattening of the isotherms could also correspond to 2D phase separation and formation of bidimensional aggregates. This is suggestive of a possible immiscibility between the two monolayer components which could be competing to stay at the interface. The mycolic acid used in the study is a mixture of different ␣ and keto mycolic acids. Each of these would unfold at different stages of compression depending upon the extent of chain folding and molecular attraction, manifesting their effects over a wide range of surface pressures. This reorientation inhibits the proper alignment and packing of DPPC molecules, which are known to otherwise form gel like rigid films. So, in effect the mixed film could contain different domains of poorly packed DPPC molecules and mycolic acid aggregates resulting in a horizontal plateau in the isotherms and higher minimum surface tensions.
The surface tension reached by increasing amounts of mycolic acid in DPPC films do not differ significantly for the higher ratios (0.75:1, 0.5:1) and lie between 18 and 19 mN/m. This result is of special significance as the minimum surface tension seems to reach a saturation value after addition of certain inhibitor amounts. This could be due to expulsion of some of the mycolic acid molecules into the subphase on compression when present in excess. The mycolic acid molecules when present in lesser amounts interfere with the DPPC molecular reorientation and packing to a lesser extent allowing decreases in the surface tension on film compression. However, even at the 0.1:1 ratio of mycolic acid:DPPC molecules, the minimum surface tension value is 8 mN/m, which can result in lung surfactant dysfunction and increased tendency of alveolar collapse.
The mycobacterial loads differ from patient to patient and with the severity of the disease. The results obtained in our studies imply that a lower bacterial load does not exclude the patient from possible lung surfactant dysfunction, as the mycolic acid molecules are inhibitory even at low concentrations.
A similar pattern of inhibition, though to a lesser extent, was exhibited by cord factor. Cord factor forms bulky molecules, with the trehalose sugar moiety known to occupy a cross sectional area of about 80Å 2 [22] . The trehalose sugars constitute the hydrophilic head group of the cord factor, which lies immersed in the subphase. These trehalose sugars on account of their inherent hydrophilic nature and larger cross sectional area could exhibit a lower surface activity and a tendency to collapse into the subphase upon compression. Unlike the mycolic acid molecules, which might coexist with the DPPC molecules over a large range of compression, the bulky cord factor molecules could undergo early exclusion from the mixed monolayer, allowing the monolayer to reach lower surface tension values. This could also explain the difference in the nature of the two isotherms. The difference in the extent of inhibition between the cord factor and mycolic acid could be attributed to the presence of the trehalose sugar moiety.
The monolayers evaluated in our study have been compressed to limiting molecular areas of around 20Å 2 , which are less than that of a double-chained phospholipid molecule. The limiting areas are close to that of single chain hydrocarbons and could be due to the collapse and aggregation of the molecules during end compression.
The compressibility analysis gives us an idea about the instability and packing deficit caused in the mixed monolayer films. The presence of mycolic acid in the DPPC film led to the formation of a highly compressible film. At surface tensions of about 30-20 mN/m a sudden increase in the compressibility is evident. This sudden increase in the compressibility indicates transient monolayer instability. In this region the monolayer isotherms also appear to be more horizontal which could be correlated to a phase transition occurring within the monolayer. The mycolic acid molecules on further compression may open up the kinked hydrocarbon chains, get unfolded and straightened up to adapt to the smaller area available. In the whole process, mycolic acid reorientation could hinder the orientation and packing of the surrounding DPPC molecules with sudden changes in compressibility.
What is evident from the compressibility analysis is the fact that presence of mycolic acid or cord factor in the DPPC film renders the film unstable at the very beginning of inspiration. This effect is more pronounced over a large range of surface tension values (from 30 to 15 mN/m), which are physiologically relevant to the equilibrium inspiratory surface tension and changes during tidal breathing. Thus presence of either of the mycobacterial cell wall lipids hinders the efficient functioning of the lung surfactant making the surfactant films unstable apart from raising the minimum surface tension values.
Of the two mycobacterial lipid films, mycolic acid-DPPC needed higher percentage area change (about 66%) as against that of cord factor-DPPC monolayer (about 46%) which also correlates well with a higher compressibility for mycolic acid-DPPC film than the CF-DPPC film. The kinked mycolic acid molecules present alone or as cord factor would require larger compression for unfolding and close packing, resulting in increased percentage area change than pure DPPC films. This result has a negative connotation for lung surfactant function as it means that in the presence of these lipids a lesser area is available in the lungs for gaseous exchange.
To sum up both mycolic acid and cord factor individually and in combination inhibited the surface activity of DPPC films. Mycolic acid is a more potent inhibitor of DPPC surface activity than cord factor. It reached higher surface tension values, higher compressibility values and caused greater increase in the percentage area change as against that of cord factor.
This could be due to the difference in their hydrophobicity and a possible early exclusion of the bulky cord factor molecules from the mixed monolayer. Difference in the extent of inhibition is thus attributed to the difference in the molecular structures of the two lipids.
Effects on DPPC:PG monolayers
The control isotherms for DPPC-PG mixtures reached higher values of minimum surface tension than that of DPPC alone. This could be due to mutual repulsion between the anionic PG head groups leading to a fluid lipid monolayer, which could interfere with packing of DPPC molecules and result in a lower surface activity. Higher minimum surface tension values were obtained when the mycobacterial lipids were present in the DPPC:PG mixed monolayers. (16.53 mN/m for mycolic acid:PL1 in 1:1 ratio and 18.15 mN/m for cord factor:PL1 in 1:1 ratio). Still higher values of surface tension were attained by the DPPC:PG monolayers used in 7:3 ratio by weight. In the presence of mycolic acid minimum surface tension of 24.22 mN/m was attained by the mycolic acid:PL2 monolayer in 1:1 ratio and 27.78 mN/m by cord factor:PL2 monolayer in 1:1 ratio by weight. Thus, the inhibitory effects of mycobacterial lipids were more pronounced in the presence of phosphatidylglycerol, a phospholipid essential for DPPC adsorption in the lung surfactant monolayer.
Unlike in the case of DPPC, cord factor was more inhibitory than mycolic acid for DPPC:PG monolayers. The cord factor molecules are acidic glycolipids. The coexistence of the anionic cord factor molecule along with the PG molecules would increase the net repulsive forces between the molecules at the interface. This could result in a further deterioration of the packing and reorientation of the surfactant molecules upon compression leading to the poor surface activity of the DPPC-PG films in presence of cord factor.
Proposed alterations in surfactant life cycle in tuberculosis
Based on our results, we propose that pulmonary surfactant lipids may interact with mycobacterial cell wall constituents, which in turn inhibit surfactant function. Fig. 8 depicts the proposed changes of the pulmonary surfactant life cycle in tuberculosis. Normally, surfactant is synthesized by type II alveolar cells and packed in lamellar bodies. The lamellar body usually opens up into tubular myelin, which forms the surfactant film at the air-aqueous interface. On expiration the surfactant film undergoes compression and other surfactant lipids collapse into the subphase leaving behind a well-packed DPPC enriched film, which is able to reach zero minimum surface tension. In tuberculosis, the mycolic acid and cord factor molecules detach from the mycobacterial cell wall and lie at the air-aqueous interface along with the surfactant molecules. On compression of the lung surfactant film, as occurs during expiration, the mycobacterial lipids remain at the interface, resist squeeze out and prevent close packing and ordering of the DPPC molecules. At the same time, they exhibit their moderate surface activity leading to a fluid monolayer, which reaches high minimum surface tension. The presence of mycobacterial lipids in the surfactant film results in inherent film instability and poor surface activity. 
Clinical implications
The surface properties of both DPPC and the DPPC-PG films in the presence of mycolic acid and cord factor are suggestive of lung surfactant dysfunction in presence of mycobacterial lipids. The deficient functioning of the surfactant monolayer film could result in areas of partial or complete atelectasis. This could lead to decreased pulmonary compliance, areas of pulmonary atelectasis and collapse which result in poor ventilation, increased work of breathing and decreased work capacity in pulmonary tuberculosis. From the studies performed, it is evident that the presence of surface-active mycobacterial lipids at the interface could result in the biophysical inhibition of the lung surfactant and have a direct role in some of the pathological features seen in tuberculosis. Biophysical inhibition of pulmonary surfactant by a variety of plasma proteins [23] , serum, erythrocytic membranes [24] and fluidizing lipids [25] have been documented in several pulmonary diseases. This implies that a physiologically unfavourable interaction between mycobacterial cell wall constituents and lung surfactant may occur which could aggravate the respiratory distress in pulmonary tuberculosis. Further studies on the role of surfactant specific proteins in the interaction between mycolic acid and surfactant lipids is required. Also, studies using captive bubble surfactometer could result in a closer simulation of the in vivo state. Nevertheless, this study establishes a biophysical inhibition of surfactant phospholipids by mycobacterial lipids for the first time. This raises the possibility of developing effective drug loaded surfactants for therapy in pulmonary tuberculosis.
Conclusion
In this study, we have established the biophysical inhibition of lung surfactant phospholipids by mycobacterial cell wall lipids, for the first time. Mycolic acid, in its free and bound form, fluidizes the lung surfactant film resulting in a high surface tension on film compression. This has implications in the pathogenesis of pulmonary tuberculosis.
